Pages that link to "Q34449990"
Jump to navigation
Jump to search
The following pages link to Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor (Q34449990):
Displaying 50 items.
- Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease? (Q21202832) (← links)
- beta-Amyloid degradation and Alzheimer's disease (Q21284467) (← links)
- A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme (Q24306614) (← links)
- Catabolic attacks of membrane-bound angiotensin-converting enzyme on the N-terminal part of species-specific amyloid-beta peptides (Q24314883) (← links)
- Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme (Q24317730) (← links)
- Cerebrovascular disease in ageing and Alzheimer's disease (Q26771852) (← links)
- β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease (Q26781608) (← links)
- Endothelin-converting enzymes and related metalloproteases in Alzheimer's disease (Q26862901) (← links)
- ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease (Q26866225) (← links)
- The genetics of Alzheimer disease (Q27026166) (← links)
- Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline (Q30572684) (← links)
- Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice. (Q30678146) (← links)
- Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease. (Q30833707) (← links)
- Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics (Q31047131) (← links)
- Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements (Q33378681) (← links)
- Identification of beta-secretase (BACE1) substrates using quantitative proteomics (Q33521280) (← links)
- Gestational protein restriction increases angiotensin II production in rat lung (Q33581546) (← links)
- An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. (Q33652202) (← links)
- The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease (Q33821846) (← links)
- Expression of ACE and ACE2 in patients with hypertensive nephrosclerosis (Q33827868) (← links)
- ACE polymorphism and use of ACE inhibitors: effects on memory performance. (Q33848704) (← links)
- Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? (Q34002989) (← links)
- ACE variants and association with brain Aβ levels in Alzheimer's disease (Q34310258) (← links)
- Unintended effects of cardiovascular drugs on the pathogenesis of Alzheimer's disease (Q34350595) (← links)
- Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation (Q34394932) (← links)
- Association of polymorphisms in the Angiotensin-converting enzyme gene with Alzheimer disease in an Israeli Arab community (Q34658026) (← links)
- Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses (Q34831241) (← links)
- Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink (Q35023755) (← links)
- The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis (Q35050809) (← links)
- Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid (Q35123119) (← links)
- The carboxypeptidase ACE shapes the MHC class I peptide repertoire (Q35402189) (← links)
- Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms (Q35564715) (← links)
- Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra. (Q35613025) (← links)
- Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies (Q36019970) (← links)
- Influence of Coding Variability in APP-Aβ Metabolism Genes in Sporadic Alzheimer's Disease (Q36036376) (← links)
- 17β-estradiol and progesterone regulate expression of β-amyloid clearance factors in primary neuron cultures and female rat brain (Q36323138) (← links)
- The involvement of lipid rafts in Alzheimer's disease (Q36447798) (← links)
- Roles of Brain Angiotensin II in Cognitive Function and Dementia (Q36487749) (← links)
- Vitamin D interacts with Esr1 and Igf1 to regulate molecular pathways relevant to Alzheimer's disease (Q36639258) (← links)
- Disease modifying therapy for AD? (Q36640414) (← links)
- Novel modulators of amyloid-beta precursor protein processing (Q36714447) (← links)
- The Role of the Renin-Angiotensin System in Amyloid Metabolism of Alzheimer's Disease (Q36721915) (← links)
- A Low-Protein Diet Enhances Angiotensin II Production in the Lung of Pregnant Rats but not Nonpregnant Rats. (Q36861080) (← links)
- Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease (Q37031522) (← links)
- Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme. (Q37107046) (← links)
- ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease (Q37139242) (← links)
- Current and future therapy in Alzheimer's disease. (Q37165703) (← links)
- Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease? (Q37200279) (← links)
- The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers. (Q37211285) (← links)
- Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension (Q37258345) (← links)